Skip to content

Caesarean Scar Defect - Prevalence and Clinical Profile

Prevalence and clinical profile of Caesarean Scar Defect after Caesarean Delivery - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103044
Enrollment
323
Registered
2026-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O342- Maternal care due to uterine scarfrom previous surgery Health Condition 2: O342- Maternal care due to uterine scarfrom previous surgery

Interventions

Intervention1: LNG IUS: Insertion of LNG IUS in patients opting for the same Control Intervention1: OCP: OCP pills administered to symptomatic patients opting for the same Control Intervention2: No in

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients delivered by caesarean delivery from Jan 2021 to June 2025 at AIIMS, New Delhi, more than 6 months before the date of recruitment CD done for any indication Patients who have one or more CD

Exclusion criteria

Exclusion criteria: Patients with underlying pre-existing uterine pathologies: endometriosis, adenomyosis, fibroid uterus, Mullerian Anomalies Age less than 18 years Patients who have undergone CS less than 6 months ago Women with classical caesarean section History of uterine surgeries Postpartum insertion of an intrauterine contraceptive device (IUCD) Pregnancy at follow up Active genital tract infection at follow-up Refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Presence or absence of CSD Timepoint: After mor than or equal to 6 months have passed the caesarean section

Secondary

MeasureTime frame
Presence or absence of symptoms in CSD Presence of CSDi Type of symptoms associated with CSD Risk factors for development of CSD Various parameters of CSD measurement & its relation to severity & type of symptoms Proportion of patients with AUB-N accepting OCPs & LNG-IUS Proportion of patients with AUB-N responding to OCPs & LNG-IUS Timepoint: After more than or equal to 6 months have passed from the caesarean section

Countries

India

Contacts

Public ContactMehak Aroa

All India Institute of Medical Sciences

aroramehak259@gmail.com9501928083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026